Paradox Immunotherapeutics
PrivateLast Round
Seed
Feb 25, 2025
Total Funding Raised
$10M
Company Overview
Paradox Immunotherapeutics is a biotechnology company developing monoclonal antibody therapies for the treatment of rare protein misfolding diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paradox Immunotherapeutics Comparables
Compare Paradox Immunotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Attralus | 78% | |
| AstraZeneca | 73% | |
| Prothena Corporation plc | 72% | |
Paradox Immunotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 25, 2025 |
Key People
Founding team and executive leadership
Paradox Immunotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2025
$10M raised in early funding.
- Feb 25, 2025
Selected for the Springboard Enterprises Life Sciences Program.
Paradox Immunotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paradox Immunotherapeutics's valuation, stock price, and market status.